- Home
- AVIR vs EXFY Comparison
AVIR vs EXFY Comparison
Compare AVIR & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- EXFY
- Stock Information
- Founded
- AVIR 2012
- EXFY 2008
- Country
- AVIR United States
- EXFY United States
- Employees
- AVIR N/A
- EXFY N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- EXFY Computer Software: Prepackaged Software
- Sector
- AVIR Health Care
- EXFY Technology
- Exchange
- AVIR Nasdaq
- EXFY Nasdaq
- Market Cap
- AVIR 273.7M
- EXFY 309.9M
- IPO Year
- AVIR 2020
- EXFY 2021
- Fundamental
- Price
- AVIR $2.85
- EXFY $2.95
- Analyst Decision
- AVIR Hold
- EXFY Buy
- Analyst Count
- AVIR 1
- EXFY 4
- Target Price
- AVIR $6.88
- EXFY $5.00
- AVG Volume (30 Days)
- AVIR 247.5K
- EXFY 398.2K
- Earning Date
- AVIR 03-06-2025
- EXFY 05-08-2025
- Dividend Yield
- AVIR N/A
- EXFY N/A
- EPS Growth
- AVIR N/A
- EXFY N/A
- EPS
- AVIR N/A
- EXFY N/A
- Revenue
- AVIR N/A
- EXFY $139,236,000.00
- Revenue This Year
- AVIR N/A
- EXFY $9.33
- Revenue Next Year
- AVIR N/A
- EXFY $5.54
- P/E Ratio
- AVIR N/A
- EXFY N/A
- Revenue Growth
- AVIR N/A
- EXFY N/A
- 52 Week Low
- AVIR $2.75
- EXFY $1.24
- 52 Week High
- AVIR $4.15
- EXFY $4.13
- Technical
- Relative Strength Index (RSI)
- AVIR 36.06
- EXFY 35.99
- Support Level
- AVIR $2.90
- EXFY $3.20
- Resistance Level
- AVIR $3.29
- EXFY $3.60
- Average True Range (ATR)
- AVIR 0.12
- EXFY 0.18
- MACD
- AVIR -0.03
- EXFY -0.04
- Stochastic Oscillator
- AVIR 8.33
- EXFY 4.41
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.